Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 9
2003 2
2004 2
2005 1
2006 4
2007 3
2008 3
2009 2
2010 5
2011 4
2012 3
2013 2
2015 6
2016 14
2017 11
2018 13
2019 15
2020 18
2021 14
2022 15
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
PET/CT in Bladder Cancer: An Update.
Bouchelouche K. Bouchelouche K. Semin Nucl Med. 2022 Jul;52(4):475-485. doi: 10.1053/j.semnuclmed.2021.12.004. Epub 2022 Jan 5. Semin Nucl Med. 2022. PMID: 34996595 Free article. Review.
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.
Ipsen MB, Sørensen EMG, Thomsen EA, Weiss S, Haldrup J, Dalby A, Palmfeldt J, Bross P, Rasmussen M, Fredsøe J, Klingenberg S, Jochumsen MR, Bouchelouche K, Ulhøi BP, Borre M, Mikkelsen JG, Sørensen KD. Ipsen MB, et al. Among authors: bouchelouche k. Oncogene. 2022 Sep;41(37):4271-4281. doi: 10.1038/s41388-022-02427-2. Epub 2022 Aug 6. Oncogene. 2022. PMID: 35933519
Letter from the Editors.
Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Semin Nucl Med. 2022 May;52(3):263-265. doi: 10.1053/j.semnuclmed.2022.03.001. Semin Nucl Med. 2022. PMID: 35461594 No abstract available.
Letter from the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Among authors: bouchelouche k. Semin Nucl Med. 2023 Jul;53(4):467-468. doi: 10.1053/j.semnuclmed.2023.05.001. Epub 2023 May 13. Semin Nucl Med. 2023. PMID: 37188566 No abstract available.
Letter From the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Among authors: bouchelouche k. Semin Nucl Med. 2023 Mar;53(2):135-137. doi: 10.1053/j.semnuclmed.2023.01.005. Epub 2023 Feb 11. Semin Nucl Med. 2023. PMID: 36775725 No abstract available.
Letter From the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Among authors: bouchelouche k. Semin Nucl Med. 2023 Nov;53(6):731-732. doi: 10.1053/j.semnuclmed.2023.09.001. Epub 2023 Sep 21. Semin Nucl Med. 2023. PMID: 37739849 No abstract available.
Letter From the Editors.
Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Semin Nucl Med. 2023 May;53(3):301-302. doi: 10.1053/j.semnuclmed.2023.01.004. Epub 2023 Feb 1. Semin Nucl Med. 2023. PMID: 36737347 No abstract available.
Letter from the Editors.
Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Semin Nucl Med. 2023 Sep;53(5):555-557. doi: 10.1053/j.semnuclmed.2023.06.008. Epub 2023 Jul 13. Semin Nucl Med. 2023. PMID: 37451935 No abstract available.
Letter from the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Among authors: bouchelouche k. Semin Nucl Med. 2023 Jan;53(1):1-3. doi: 10.1053/j.semnuclmed.2022.11.002. Semin Nucl Med. 2023. PMID: 36460419 No abstract available.
Letter From the Editors.
Sathekge MM, Bouchelouche K. Sathekge MM, et al. Among authors: bouchelouche k. Semin Nucl Med. 2024 Mar;54(2):183. doi: 10.1053/j.semnuclmed.2024.01.009. Epub 2024 Feb 14. Semin Nucl Med. 2024. PMID: 38360441 No abstract available.
146 results